Financhill
Back

Lantern Pharma Quote, Financials, Valuation and Earnings

Buy
66

LTRN
Lantern Pharma

Last Price:
6.13
Seasonality Move:
0.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Lantern Pharma Price Quote

$6.13
+0.10 (+-0.16%)
(Updated: May 18, 2024 at 5:48 AM ET)

Lantern Pharma Key Stats

Buy
66
Lantern Pharma (LTRN) is a Buy

Day range:
$5.90 - $6.33
52-week range:
$2.38 - $11.99
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.81%

Volume:
43.8K
Avg. volume:
157K
1-year change:
23.06%
Market cap:
$64.9M
Revenue:
$0
EPS:
$-1.63

How Much Does Lantern Pharma Make?

Data Unavailable

Is Lantern Pharma Growing As A Company?

Data Unavailable

Lantern Pharma Stock Price Performance

  • Did Lantern Pharma Stock Go Up Last Month?
    Lantern Pharma share price went up by 0.67% last month
  • Did LTRN's Share Price Rise Over The Last Year?
    LTRN share price rose by 23.06% over the past 1 year

What Is Lantern Pharma 52-Week High & Low?

Lantern Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Lantern Pharma?

  • How Much Debt Does Lantern Pharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Lantern Pharma Have?
    Cash and short term investments quarterly total is $38.4M
  • What Is Lantern Pharma’s Book Value Per Share?
    Book value per share is 3.32

Is Lantern Pharma Cash Flow Positive?

  • What Is LTRN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$13.7M
  • What Is Lantern Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$445.3K
  • What Is Lantern Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$525.5K

Lantern Pharma Return On Invested Capital

Data Unavailable

Lantern Pharma Earnings Date & Stock Price

Lantern Pharma Competitors

  • Who Are Lantern Pharma's Competitors?
    Below is a list of companies who compete with Lantern Pharma or are related in some way:
    • Alpine Immune Sciences Inc (ALPN)
    • Clearside Biomedical Inc (CLSD)
    • Eyenovia Inc (EYEN)
    • Poseida Therapeutics Inc (PSTX)
    • Cassava Sciences Inc (SAVA)

Lantern Pharma Dividend Yield

Data Unavailable

Lantern Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -18.61%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 22.00
Upside from Last Price: 264.84%

Major Shareholders

  • How many LTRN shares are owned by institutional investors?
    2.2M LTRN shares are owned by institutional investors
  • How many LTRN shares are owned by insiders?
    483.9K LTRN shares are owned by insiders